Ontology highlight
ABSTRACT:
SUBMITTER: Kim P
PROVIDER: S-EPMC8138826 | biostudies-literature | 2021 May
REPOSITORIES: biostudies-literature
Kim Pora P Li Hanyang H Wang Junmei J Zhao Zhongming Z
Briefings in bioinformatics 20210501 3
More than 48 kinase inhibitors (KIs) have been approved by Food and Drug Administration. However, drug-resistance (DR) eventually occurs, and secondary mutations have been found in the previously targeted primary-mutated cancer cells. Cancer and drug research communities recognize the importance of the kinase domain (KD) mutations for kinasopathies. So far, a systematic investigation of kinase mutations on DR hotspots has not been done yet. In this study, we systematically investigated four type ...[more]